Although the profound growth inhibition due to TP53 was further increased by gemcitabine, induction of the tumour suppressor did not appreciably protect the cells from gemcitabine or sensitise them to treatment (data not shown or Figure 1F). This evidence concerns the gene TP53 and neoplasm.